Key facts
- Notable investors include Leaguer Financial, Miracle Light Venture, Shenzhen Lihe Science and Technology Innovation.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Bay Shadow Technology
- ·The full record, as it builds
Funding rounds
No funding rounds for Bay Shadow Technology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Bay Shadow Technology
Developer of molecular imaging technology intended for brain-specific and small animal positron emission tomography tracks. The company offers customizable axial length for non-invasive, high-resolution acquisition of biomolecular imaging, anesthesia for various animal experiments, and drug injection for mice, catering to the research and development industry with anesthesia induction and maintenance of a constant temperature, allowing non-invasively and quantitative observation.
- Sector
- Information Technology
- HQ
- Shenzhen, China
- Founded
- 2022
- Employees
- 11
- Website
- bayimaging.tech/
- Ownership
- Privately Held (backing)
Bay Shadow Technology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Bay Shadow Technology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Bay Shadow Technology in its N-PORT filings yet. We sweep new filings monthly.